References
- Coutts R. T., Dawson G. W., Jones G. R. In vivo metabolism of N-alkyl amphetamines in the rat—the effect of N-alkyl chain length on oxidation of the aromatic ring. Research Communications in Chemical Pathology and Pharmacology 1978; 22: 589–592
- Darlington W. H., Baczynskyj L., Mizsak S. A., Scahill T. A., Dring L. G., McCall J. M., Szmuszkovicz J. Isolation, identification and synthesis of a metabolite of tazadolene succinate. Drug Design and Delivery 1987; 1: 225–230
- Drin L. G., Smith R. L., Williams R. T. The fate of amphetamine in man and other mammals. Journal of Pharmacy and Pharmacology 1966; 18: 402–405
- Hucker H. B., Gillette J. R., Brodie B. B. Enzymatic pathway for the formation of cotinine, a major metabolite of nicotine in rabbit liver. Journal of Pharmacology and Experimental Therapeutics 1960; 129: 94–100
- Metzler C. M., Elfring G. L., McEwen A. J. Package of computer programs for pharmacokinetic modeling. Biometrics 1974; 30: 562–563
- Nakagawa H., Matsubara Y., Yamano S., Hiraoka K., Suga T. Metabolic fate of dl-erythro-2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-1-propanol. II. Separation and identification of metabolites in urine and bile of rats. Pharmacometrics 1975; 10: 841–848
- Piercey M. F. Tazadolene: a centrally-acting, non-narcotic analgesic. Drug Development Research 1988; 13: 269–274
- Sinsheimer J. E., Dring L. G., Williams R. T. Species differences in the metabolism of norephedrine in man, rabbit and rat. Biochemical Journal 1973; 136: 763–771
- VonVoigtlander P. F., Chidester C. G., Kane M. P., Szmuszkovicz J. Tazadolene succinate: a structurally novel non-opioid analgesic with antidepressent properties. Drug Design and Delivery 1986; 1: 103–108